Anzeige
Mehr »
Login
Samstag, 02.12.2023 Börsentäglich über 12.000 News von 684 internationalen Medien
Trend 2024: Reich werden mit dieser Nickel-Aktie?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 850943 | ISIN: US7140461093 | Ticker-Symbol: PKN
Tradegate
01.12.23
16:11 Uhr
81,68 Euro
-2,22
-2,65 %
Branche
Sonstige Technologie
Aktienmarkt
S&P 500
1-Jahres-Chart
REVVITY INC Chart 1 Jahr
5-Tage-Chart
REVVITY INC 5-Tage-Chart
RealtimeGeldBriefZeit
82,9884,6613:00
83,6884,0801.12.

Aktuelle News zur REVVITY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
Fr Revvity (RVTY) Launches New Molecular Testing for Newborns2
MoRevvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID203Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities Today, Revvity, Inc., announced the launch of its EONIS...
► Artikel lesen
07.11.REVVITY, INC. - 10-Q, Quarterly Report6
31.10.Revvity shares plummet following disappointing Q3 results and forecast cut13
30.10.Why Revvity Stock Plunged Today16
30.10.Massive Kursverluste für die Aktie von PerkinElmer (78,7494 €)530Zu den großen Verlierern an der Börse zählt heute das Wertpapier von PerkinElmer . Das Wertpapier verliert deutlich an Wert. Kein guter Tag bislang für Inhaber von PerkinElmer: Das Wertpapier weist...
► Artikel lesen
30.10.Revvity Inc. Stock Plunges Amid Missed Q3 Earnings And Reduced Annual Outlook10
30.10.Revvity's disappointing Q3 report weighs on life sciences tool stocks10
30.10.Revvity sinks after third quarter results disappoint investors4
30.10.Revvity says demand to stay weak on biotech funding woes8
30.10.Revvity slumps on annual forecast cut, Q3 results miss4
30.10.Why Biotechnology Company Revvity's Shares Diving Today5
30.10.Revvity Inc reports results for the quarter ended in September - Earnings Summary2
30.10.Revvity falls on annual forecast cut, Q3 results miss3
30.10.Revvity cuts annual forecast on weak demand for diagnostics, contract research4
30.10.Revvity Cuts Annual Outlook Below View289WASHINGTON (dpa-AFX) - Revvity Inc. (RVTY) on Monday revised down its full-year 2023 guidance below analysts' estimates. For full year 2023, RVTY now expects adjusted earnings per share of $4.53...
► Artikel lesen
30.10.Revvity Announces Financial Results for the Third Quarter of 2023193WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended October 1, 2023. The Company reported GAAP earnings per share of $0.08...
► Artikel lesen
30.10.Revvity, Inc. Announces Fall In Q3 Bottom Line, misses estimates315WASHINGTON (dpa-AFX) - Revvity, Inc. (RVTY) reported a profit for third quarter that decreased from last year and missed the Street estimates.The company's bottom line came in at $9.497 million...
► Artikel lesen
30.10.Revvity misses Q3 top and bottom line estimates; narrows FY23 outlook5
27.10.Earnings Outlook For Revvity2
Seite:  Weiter >>
56 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1